Flaccid Bladder: Causes, Symptoms, and Treatment

A flaccid bladder, sometimes called an atonic or underactive bladder, is a condition in which the bladder muscle loses its ability to contract with enough force to empty properly. Instead of squeezing urine out in a coordinated stream, the bladder sits overfull and stretched, leaving behind large volumes of residual urine. The underlying problem is almost always nerve damage or muscle deterioration that disrupts the signaling chain between the brain, spinal cord, and the bladder wall. While it shares some symptoms with other urinary disorders, a flaccid bladder has distinct causes, risks, and management strategies that set it apart.

How Normal Bladder Emptying Works

Your bladder empties through a tightly coordinated reflex. Nerve signals originating from the sacral spinal cord (roughly the S2 through S4 levels) travel through the pelvic nerves to the bladder wall, where they release a chemical messenger called acetylcholine. That chemical activates receptors on the smooth muscle of the bladder (called the detrusor), causing it to contract while the urethral sphincter simultaneously relaxes.¹ A flaccid bladder develops when any link in this chain breaks down: the nerves sending signals, the muscle receiving them, or the receptors translating the message into contraction. The result is a bladder that fills but cannot generate the pressure needed to push urine out.

What Causes a Flaccid Bladder

The causes fall into a few broad categories, but they all share a common endpoint: the detrusor muscle either never receives the signal to contract, or it has deteriorated so much that it can no longer respond.

Diabetes

Diabetes is one of the most common causes in the general population. Chronically elevated blood sugar damages the small nerve fibers that supply the bladder, a process that tends to develop slowly over years. The earliest sign is often a loss of bladder sensation, meaning you don’t feel the urge to urinate until the bladder is abnormally full. Over time, the bladder stretches beyond its normal capacity and the detrusor weakens, leading to large volumes of leftover urine after voiding and eventually overflow incontinence.² This pattern, sometimes called diabetic cystopathy, has been shown to occur regardless of how long someone has had diabetes or how severe it is. Researchers have linked it to broader peripheral nerve damage detected through other tests of the autonomic nervous system.³

A urodynamic study of diabetic men with urinary symptoms illustrates how varied the picture can be. About a quarter had a first bladder sensation delayed beyond 250 mL, a quarter had bladder capacity above 600 mL, and roughly four in five showed detrusor underactivity. Both sensory and motor forms of bladder dysfunction correlated with abnormal nerve conduction studies in the limbs, reinforcing the idea that what happens in the bladder mirrors nerve damage elsewhere in the body.⁴

Spinal Cord and Neurological Conditions

Any disease or injury that damages the sacral spinal cord or the nerves running from it can produce a flaccid bladder. Spinal cord injuries at or below the sacral level are a classic cause. So are conditions like multiple sclerosis, spina bifida, and cauda equina syndrome. Congenital anomalies such as meningomyelocele (the most common form of spina bifida) frequently produce neurogenic bladder dysfunction from birth, and without management can lead to progressive kidney damage, recurrent infections, and significant social difficulties related to incontinence.⁵

In animal models of multiple sclerosis, researchers have documented that the bladder undergoes significant remodeling as the disease progresses. The ratio of connective tissue (essentially scar-like material) to functional muscle increases, while the expression of nerve growth factors and the receptors that muscle cells need to respond to nerve signals decreases.⁶ This means the bladder doesn’t just lose its nerve supply; the muscle itself structurally changes in ways that make recovery harder.

Pelvic Surgery

Major pelvic surgery is another well-recognized cause. Procedures for cervical, rectal, or prostate cancer can damage the fine nerve branches that run through the pelvic region on their way to the bladder. Radical hysterectomy, for instance, sometimes requires cutting through tissue that houses these nerve fibers. The resulting denervation can cause the detrusor to become atonic, leading to chronic urinary retention and a cascade of complications including recurrent infections.⁷

Less Common Triggers

Herpes zoster (shingles) affecting the S2 through S4 nerve roots can cause acute urinary retention even in people with healthy immune systems. This is uncommon, but case reports document it happening after a shingles outbreak in the buttock or perineal region.⁸ Other rarer causes include heavy metal poisoning, certain medications (particularly anticholinergic drugs used long-term), and prolonged overdistention from any cause, which can permanently stretch and damage the detrusor muscle fibers.

Recognizing the Symptoms

The hallmark of a flaccid bladder is difficulty emptying rather than difficulty holding urine. People often report a weak or interrupted stream, a sensation that the bladder hasn’t fully emptied, and sometimes the need to press on the lower abdomen (a technique called Credé maneuver) to help push urine out. Paradoxically, incontinence is also common, specifically overflow incontinence: the bladder becomes so full that small amounts of urine leak out continuously, especially at night.

A reduced or absent urge to urinate is another distinctive feature, particularly in diabetes-related cases. Where a healthy person typically feels a first urge at around 150 to 250 mL of filling, someone with a flaccid bladder may not feel anything until the bladder holds 400 mL or more. Frequent urinary tract infections are often what finally bring people to a doctor, since the stagnant residual urine creates an ideal environment for bacteria.

How a Flaccid Bladder Is Diagnosed

A doctor can suspect the diagnosis based on symptoms and a physical exam (a distended, non-tender bladder palpable above the pubic bone is a strong clue), but confirming it usually requires urodynamic testing. This involves placing a small catheter in the bladder and measuring how much the bladder holds, what pressures it generates during filling and emptying, and how effectively the detrusor contracts. The challenge is that there is no single universally agreed-upon cutoff for what counts as an “underactive” detrusor. Diagnostic criteria rely on various approximations of bladder contractility measured during urodynamics, and most of these methods have significant limitations or are not yet well validated.⁹

How the criteria are defined makes a big difference in how many patients get the diagnosis. In one study comparing different urodynamic criteria in men, the estimated prevalence of detrusor underactivity ranged from as low as 5% to as high as 56% depending on which formula was used.¹⁰ This lack of standardization makes it harder to compare studies and can lead to under- or over-diagnosis depending on which clinic you visit.

Non-Invasive Alternatives

Because urodynamics is invasive and uncomfortable, researchers have been working on ultrasound-based approaches. One method measures detrusor wall thickness combined with bladder capacity. A thin detrusor wall (1.23 mm or less) combined with a large bladder capacity (over 445 mL) was found to be 100% specific for detrusor underactivity, meaning it virtually never produced a false positive. However, it only caught about 42% of actual cases, so a normal ultrasound reading doesn’t rule it out.¹¹

Another approach looks at the ratio of detrusor muscle thickness to total bladder wall thickness, essentially measuring how much of the bladder wall is still functional muscle versus non-contractile tissue. A ratio below about 47.5% (measured early in filling) showed good accuracy for identifying underactivity and has been described as a form of “detrusor sarcopenia,” drawing an analogy to the age-related loss of skeletal muscle.¹² These non-invasive tools are still being refined, but they represent a promising direction, especially for patients who need repeated monitoring.

What Happens If It Goes Untreated

A flaccid bladder is not just an inconvenience. The complications can be serious and, in some cases, life-threatening. The most immediate risk is urinary tract infection. Stagnant urine is a breeding ground for bacteria, and people with neurogenic bladders face a higher-than-average risk of severe infections, including urosepsis. Risk factors include the residual urine itself, elevated bladder pressures, bladder stones that form in stagnant urine, and the use of catheters.¹³

The longer-term danger is damage to the kidneys. When the bladder stays chronically distended, back-pressure can be transmitted up the ureters, leading to hydronephrosis (swelling of the kidneys). In its most severe form, high-pressure chronic retention produces bilateral hydronephrosis, high blood pressure, and progressive kidney failure that can be fatal if not addressed.¹⁴ Even in less extreme cases, chronic urinary retention can cause functional obstruction at the junction where the ureters meet the bladder, contributing to gradual kidney deterioration.¹⁵

Catheterization as the First Line of Management

For most people with a flaccid bladder, the cornerstone of management is clean intermittent catheterization. This involves inserting a thin catheter through the urethra several times a day to drain urine, then removing it. It sounds daunting, but most patients learn to do it themselves with practice, and it remains the most reliable way to keep the bladder empty and prevent the complications described above.

A common concern is whether intermittent catheterization carries a lower infection risk than a permanently placed (indwelling) catheter. A study comparing the two methods found that at any given visit, about 8% of patients in each group had a UTI. Over a 12-month period, roughly 44 to 46% of patients using either method experienced at least one UTI.¹⁶ The rates were statistically indistinguishable, which may surprise people who have been told intermittent catheterization is clearly safer. In practice, the choice often depends on the patient’s hand function, mobility, and preference, with intermittent catheterization still preferred for its other benefits, such as preserving some natural bladder cycling and avoiding the constant presence of a foreign body.

Medications and Their Limitations

Drug options for a flaccid bladder are frustratingly limited. Bethanechol, a medication that mimics the chemical signal (acetylcholine) the bladder normally uses to contract, has been prescribed for decades. The logic is straightforward: if the muscle isn’t getting enough stimulation, give it more. In practice, though, the evidence for bethanechol is weak. A meta-analysis found it to be ineffective at promoting bladder emptying, and most reports of clinical benefit have been anecdotal rather than based on controlled trials.¹⁷ A separate review confirmed that while bethanechol may theoretically improve detrusor contractility, its real-world clinical benefit remains limited.¹⁸

A more promising approach combines a cholinergic drug with an alpha-blocker (a medication that relaxes the bladder neck and urethra). In a study of patients with detrusor underactivity, neither drug alone significantly improved urinary flow rate, but the combination therapy significantly increased both average and peak flow rates compared to baseline. Post-void residual volume also dropped significantly with the combination.¹⁹ Still, even combination therapy falls short for many patients, and medications alone rarely eliminate the need for catheterization in people with severe underactivity.

Sacral Neuromodulation

When medications and catheterization are not enough, sacral neuromodulation offers a different approach. A small device similar to a cardiac pacemaker is implanted near the sacral nerves and delivers gentle electrical impulses to the nerve pathways that control the bladder. The idea is to “wake up” nerve circuits that have become sluggish rather than to directly stimulate the bladder muscle.

In a study of women with idiopathic (no identifiable structural cause) urinary retention that had not responded to other treatments, 90% had a successful trial phase with more than 50% improvement in voiding. After permanent implantation and a median follow-up of about 28 months, 79% maintained clinical success. Their post-void residual volume dropped from an average of roughly 330 mL to about 97 mL, average voided volume jumped from about 60 mL to 265 mL, and the number of daily catheterizations fell from about 5.6 to 1.3.²⁰ These are striking improvements, though it’s worth noting that the patients were carefully selected and the condition was idiopathic, meaning results may differ in people whose flaccid bladder stems from established nerve damage or systemic disease.

Surgical Options for Severe Cases

For patients who cannot catheterize, don’t respond to neuromodulation, or have a completely acontractile bladder, surgical options exist, though they are complex. One of the more innovative procedures is latissimus dorsi detrusor myoplasty, in which a strip of muscle from the patient’s back is surgically wrapped around the bladder to serve as a substitute detrusor. The transplanted muscle provides the contractile force the native bladder can no longer generate.²¹

Long-term results from a series of 24 patients who underwent this procedure showed that 71% regained complete spontaneous voiding with a mean residual urine of just 25 mL. Their bladder contractility index jumped dramatically after surgery. Another 13% saw a meaningful reduction in how often they needed to catheterize.²² The procedure requires a multidisciplinary team of urologists and plastic surgeons, limiting it to specialized centers, and not every patient is a candidate. But for the right person, it can mean the difference between lifelong catheterization and independent voiding.

Experimental Treatments on the Horizon

Stem cell therapy has moved from laboratory curiosity to early clinical testing for detrusor underactivity. In an open clinical trial, patients received injections of their own adipose-derived (fat-derived) mesenchymal stem cells directly into the bladder wall. After treatment, peak urine flow more than doubled from roughly 4.8 mL per second to about 11.6 mL per second. Maximum detrusor pressure roughly doubled as well, and the bladder contractility index rose from about 44 to over 100, crossing from the underactive range into the normal range.²³ These are early results from a small, uncontrolled trial, so they should be interpreted cautiously. But they suggest that regenerating bladder muscle function, rather than merely bypassing or replacing it, might become feasible.

Animal studies have also explored amniotic fluid stem cells for bladder dysfunction caused by chronic obstruction, finding improvements in detrusor function along with reduced inflammation and scarring in the bladder wall. The gap between animal research and human treatment remains wide, but the consistency of positive signals across different stem cell types and delivery methods has sustained interest in the field.

How the Bladder Wall Changes Over Time

One reason flaccid bladder can be so difficult to reverse is that the bladder doesn’t simply wait around for nerve signals to return. It actively remodels. In conditions that cause chronic overdistention or obstruction, the smooth muscle cells of the detrusor enlarge (hypertrophy), and the wall’s architecture shifts. Studies of patients with bladder outlet obstruction have shown that the muscle cells grow significantly in diameter compared to healthy tissue, even though the number of cells doesn’t increase.²⁴ Over time, connective tissue infiltrates the muscle layer, reducing the proportion of contractile tissue. This connective tissue replacement is particularly pronounced in neurogenic bladder conditions, where it appears to be driven by specific growth factors that accelerate fibrosis.⁶

This remodeling has a practical implication: the longer a flaccid bladder goes untreated, the harder it becomes to restore function. Early intervention to keep the bladder draining, even through intermittent catheterization, may slow or prevent some of this structural deterioration. The window for neurological recovery (in cases where nerve repair is possible) also narrows as the muscle itself becomes less capable of responding, even if the nerve signals eventually return.

Living with a Flaccid Bladder

The daily reality of managing a flaccid bladder goes well beyond the medical specifics. Catheterizing several times a day takes time and requires clean supplies and a private space. Travel, work, and social situations all require planning around catheterization schedules. Overflow incontinence, when it occurs, carries its own psychological burden, affecting self-confidence and social participation. Skin breakdown from chronic moisture exposure is a physical risk that compounds the emotional toll.

Sleep disruption is another underappreciated issue. Nighttime incontinence (enuresis) is a recognized feature of chronic retention, and many patients set alarms to catheterize overnight, fragmenting their sleep in ways that affect energy, mood, and overall health. Support groups and continence nurses can make a real difference for people navigating these challenges, both practically and emotionally. The condition is far more common than public conversation suggests, and isolation tends to worsen outcomes in ways that are hard to measure but easy to observe.